Effect of phosphorylation on the structure and fold of transactivation domain of p53 by Kar, Sanchari et al.
Effect of Phosphorylation on the Structure and Fold of
Transactivation Domain of p53*
Received for publication, July 23, 2001, and in revised form, February 7, 2002
Published, JBC Papers in Press, February 19, 2002, DOI 10.1074/jbc.M106915200
Sanchari Kar‡§, Kazuyasu Sakaguchi¶, Yasuyuki Shimohigashi¶, Soma Samaddar‡§,
Raja Banerjee‡, Gautam Basu‡**, V. Swaminathan§‡‡, Tapas K. Kundu‡‡§§,
and Siddhartha Roy‡**¶¶
From the ‡Department of Biophysics, Bose Institute, P-1/12 C. I. T., Scheme VII M, Calcutta 700 054, India,
the ¶Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Sciences, Kyushu University,
Fukuoka 812-8581, Japan, and the ‡‡Transcription and Disease Laboratory, Molecular Biology and Genetics Unit,
Jawaharlal Nehru Center for Advanced Scientific Research, Jakkur, Bangalore 560064, India
Several phosphorylations are known to occur in the
N-terminal transactivation domain of human p53. To
explore the structural effects of these phosphorylations,
we have chemically synthesized the unphosphorylated
p53-(1–39) and its three phosphorylated analogs, phos-
phorylated at Ser-15, Thr-18, and Ser-20. p53-(1–39) and
its Ser-15 and Thr-18 phosphorylated analogs were
tested for interaction with p300. The order of binding
affinities was similar to that derived from biochemical
experiments with the whole protein, indicating func-
tional integrity of the domain. Differences in chemical
shifts and coupling constants indicate significant struc-
tural changes upon phosphorylations. The single tryp-
tophan in the unphosphorylated domain has an emis-
sion maximum and a Stern-Volmer constant that are
characteristics of tryptophans situated in protein inte-
riors. The diffusion constant is monomer-like, with an
axial ratio of 1:7.5, indicating a significant degree of
compaction. Upon phosphorylations, the emission max-
imum and diffusion constant change significantly to-
ward values that indicate more open conformations.
Binding of the hydrophobic probe bis-1-anilino-8-naph-
thalenesulfonate to the unphosphorylated and one of
the phosphorylated domains is also significantly differ-
ent, suggesting different conformations. We propose
that phosphorylations switch the largely folded transac-
tivation domain to more open conformations that inter-
act with transcription factors such as p300/cAMP-
responsive element-binding protein-binding protein,
leading to enhancement of gene expression.
p53 lies at the center of the cellular response to genotoxic
stress. Various stress signals integrate by means of post-trans-
lational modifications of the p53 protein, resulting in different
downstream responses (1). A major response is to halt cell cycle
progression with corresponding activation of genes needed for
DNA repair. A second kind of response is apoptosis (2). Geno-
toxic stresses activate many cellular kinases that phosphoryl-
ate various serine and threonine residues in p53, as well as
enzymes that cause lysine acetylations (3). Presently, at least
12 serine/threonines and 2 lysines are known to be modified in
p53 and there may be more modification sites. This signaling
system and the code of post-translational modification are still
incompletely understood (1). An understanding of the struc-
tural basis of such signal integration and transduction remains
a distant dream.
p53 is a multidomain protein. The N-terminal domain 1–73
is responsible for transactivation function and binding of such
proteins as Mdm2/Hdm2, which down-regulate the levels of
p53 (4). The N-terminal domain of p53 is emerging as one of the
most important regions in p53 function. One of the major
pathways of transactivation is through interaction with p300/
CBP1 and recruitment of this protein to the required promoter
region. p300/CBP has well known histone acetyltransferase
activity, which results in histone acetylation and remodeling of
the chromosome in that region leading to enhanced transcrip-
tion (5). Clearly, interactions of the N-terminal domain of p53
with Mdm2 and p300/CBP and possibly with other regulatory
proteins are of crucial importance in understanding the various
roles played by p53 as the guardian of the genome.
Although crystal or NMR structures of other domains have
been reported (6, 7), very little is known about the structure of
this important domain. Only very recently, an NMR study of
this domain has shown this to be disordered, although the
authors concluded that secondary structural elements are pres-
ent (8). It now appears that there are at least eight phospho-
rylation sites within the N-terminal subdomain: serines 6, 9,
15, 20, 33, 37, and 46 and threonine 18 (1). Functions of several
of these phosphorylations are not clear. However, it appears
that the Ser-15 phosphorylation plays a crucial role in the
transactivation process (9–11). Phosphorylation of Ser-15 oc-
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other things, this phosphorylation leads to phosphorylation of
the Thr-18 by casein kinase-1 (13) and consequent inhibition of
interaction of p53 with Mdm2 (14). Ser-15 phosphorylation also
leads to greatly increased binding of p53 to CBP/p300. It is also
possible that the phosphorylation of Ser-15 leads to an en-
hancement of acetylation of C-terminal lysines and has some
effect on p53 mediated apoptosis (15). Such multiple effects of
a single phosphorylation suggest that this phosphorylation
may be causing a conformational change in the transactivation
domain of the protein. Similarly, phosphorylation at Ser-20 has
been implicated in various downstream responses (10, 16, 17).
In this study we have focused our attention on the structural
consequences of the phosphorylation of Ser-15, Thr-18, and
Ser-20 in the N-terminal domain. Because it is difficult to
produce specifically phosphorylated derivatives of the whole
protein, we have chosen to study the N-terminal subdomain
1–39, which can be chemically synthesized in phosphorylated
forms in large quantities.
EXPERIMENTAL PROCEDURES
Materials
Fmoc amino acids were purchased from Novabiochem (San Diego,
CA). Vydac C-8 column was purchased from Grace-Vydac (Hesperia,
CA). All other materials were of high quality analytical grade.
Methods
Expression and Purification of p300—His6-tagged recombinant full-
length p300 was expressed in Sf21 insect cells by using the baculovirus
expression system and purified by nickel-nitrilotriacetic acid affinity
purification as described previously (18). Briefly, Sf21 cells were in-
fected with the recombinant baculovirus for 72 h, following which they
were harvested and homogenized in a homogenization buffer (10 mM
Tris-HCl, pH 7.5, containing 10% glycerol, 0.1% Nonidet P-40, 2 mM
-mercaptoethanol, 2 mM phenylmethylsulfonyl fluoride, 50 g/ml leu-
peptin, 50 g/ml aprotinin, 500 mM NaCl, and 15 mM imidazole). The
cleared lysate was bound to the nickel-nitrilotriacetic acid-agarose
beads (Qiagen GmbH) and washed in the same buffer with 300 mM
NaCl and 15 mM imidazole. The protein was eluted in the homogeniza-
tion buffer containing 200 mM NaCl and 250 mM imidazole. The purified
protein showed a single band upon Coomassie stain and Western blot.
It was also fully functional by histone acetyltransferase assay.
Peptide Synthesis and Characterization—The p53-(1–39) peptide and
its phosphorylated derivatives were synthesized by the solid phase
method with Fmoc chemistry using a model 430A peptide synthesizer
(Applied Biosystems, Foster City, CA). Phosphoserine was incorporated
as Fmoc-Ser(PO(OBzl)OH)-OH, and phosphothreonine was incorpo-
rated as Fmoc-Thr(PO(OBzl)OH)-OH. Peptides were cleaved from the
resin, and side-chain protecting groups were removed by incubating in
reagent K (trifluoroacetic acid:phenol:thioanisole:H2O:ethanedithiol,
82.5:5:5:5:2.5) for 3 h at room temperature. The p53-(1–39) peptide and
its phosphorylated derivatives were purified by HPLC on a pH-stable
Vydac C-8 column with 0.2% hexafluoroacetone-NH4OH, pH 7.0, ace-
tonitrile. The masses of peptides were confirmed by matrix-assisted
laser desorption ionization time-of-flight mass spectrometry on a Voy-
ager PR-HR (PerSeptive Biosystems, Framingham, MA).
Another truncated version of p53, Pep53-(17–28) and a variant
(Bpep53; see below for the sequence) were synthesized in a Biolynx
4175-peptide synthesizer using Fmoc protocol. Amino acids, except
those stated below, were used as N-terminal Fmoc-protected and C-
terminally pentafluorophenyl ester-activated with N-hydroxybenzotria-
zole. -Aminoisobutyric acid (Aib), Asp, and Thr were used in the
COOH form using benzotriazole-1-yloxytrispyrrolidinophosphonium
hexafluorophosphate as activating agent with N-hydroxybenzotriazole
and N,N-diisopropyl ethylamine (1:1:2). The peptides were acetylated
at the N terminus using acetic anhydride and triethylamine (1:1) and
cleaved from the resin (Novasyn KA) with trifluoroacetic acid:ethanedi-
thiol:anisole:phenol (94:2:2:2, v/v/v/w). Both the peptides were purified
by reverse phase HPLC on C-18 (Waters Associates) column using
0–60% acetonitrile in 0.1% trifluoroacetic acid and characterized by
NMR. The sequences of the two peptides are ETFSDLWKLLPE (Pep53)
and BTFBDBWKBLBE (Bpep53), where B stands for Aib.
NMR Spectroscopy—All NMR spectra were taken in a Bruker DRX-
500 NMR spectrometer equipped with a Z-field gradient probe. All
measurements were done in high precision 5-mm NMR tubes in 10 mM
phosphate buffer, pH 7.0, containing 100 mM NaCl in 90% H2O and 10%
D2O. All NMR experiments were done at 27 °C, unless stated otherwise.
TOCSY and NOESY spectra were measured using standard pulse se-
quences in the Bruker pulse library using WATERGATE water sup-
pression method. The diffusion measurements were carried out by
stimulated echo-based pulse sequence (90° gradient pulse, 90° delay for
diffusion, 90° gradient pulse acquisition). Typical delay for diffusion
was set at 200 ms (202.244 (  in the equation below) ms counting
finite length of the pulses) (19). The strength of the gradient (G) pulse
was varied, and G2 versus ln[intensity] was plotted. The strength of the
gradient and the intensity are related by the following equation.
lnI G 2 D  /3 (Eq. 1)
I is the intensity,  is the gyromagnetic ratio, D is the diffusion con-
stant,  is the delay between the first two 90° pulses,  is the delay
between two gradient pulses (includes delay for diffusion), and G is the
strength of the gradient pulse. From the slope of the line, D can be
calculated, because all other parameters are known. D20,w values were
calculated according to Cantor and Schimmel (20). Perrin factors and
hydrodynamic radii were calculated from diffusion constants according
to Cantor and Schimmel (20). The temperature was 27 °C. JNH-H
values were derived from double quantum-filtered COSY spectra ac-
cording to Kim and Prestegard (21).
Circular Dichroism—CD spectra were measured in a Jasco J-700
spectropolarimeter in 10 mM phosphate buffer, pH 7, containing 100 mM
NaCl. The cuvette path length was 2 mm. Temperature was 7.5 °C. The
bandwidth was 2 nm, and scan speed was 20 nm/min.
Fluorescence Measurements—All fluorescence spectra were meas-
ured in a Hitachi F-3010 fluorescence spectrophotometer at ambient
temperature (25  1 °C), unless stated otherwise. Acrylamide quench-
ing was done in 10 mM phosphate buffer, pH 7, containing 100 mM
NaCl. The observed fluorescence values were corrected for volume
change and inner filter effect. Inner filter effect was corrected using the
formula Fcorr  Fobs 	 antilog[(Aex 
 Aem)/2]. The excitation wavelength
was 295 nm, and the emission wavelength was 340 nm. Excitation and
emission band passes were 5 nm each. The quenching data was fitted to
the Stern-Volmer equation: F0/F  1 
 Ksv[Q], where F0 is the fluores-
cence intensity at zero quencher concentration, F is the intensity at a
given quencher concentration Q, and Ksv is the Stern-Volmer constant.
Bis-ANS binding was carried out in 10 mM phosphate buffer, pH 7.0,
containing 100 mM NaCl. Excitation and emission band passes were set
to 5 nm. 10 M p53-(1–39) or Ser20P was titrated with increasing
concentrations of bis-ANS, and fluorescence intensity at 490 nm was
recorded. The excitation wavelength was 387 nm. Fluorescence inten-
sities were corrected for volume changes and inner filter effect.
Interaction of p53-(1–39) Domain and Its Derivatives with p300—
Ser15P was labeled with fluorescein isothiocyanate at low pH so that
the modification may be primarily directed toward the N terminus
(resulting from lower pK of the -amino group (Ref. 22)). 7.7 M Ser15P
was mixed with 20-fold molar excess of fluorescein isothiocyanate in 5%
v/v ethanol (final concentration) in 0.2 M potassium phosphate, pH 6.0,
at 25 °C, with continuous stirring for 4 h. It was then centrifuged, and
the supernatant was loaded on to a Sephadex G-25 column, equili-
brated, and eluted with 20 mM Tris-HCl, pH 7.9, containing 100 mM
KCl. For direct titration, 720 nM fluorescein-labeled Ser15P in 20 mM
Tris-HCl buffer, pH 7.9, containing 100 mM KCl was titrated with p300,
and the anisotropy was determined at each point. The excitation wave-
length was 480 nm, and the emission wavelength was 520 nm. For the
competition experiments, 360 nM labeled Ser15P was mixed with 360
nM p300 in 20 mM Tris-HCl, pH 7.9, containing 100 mM KCl buffer and
incubated for 5 min. This buffer was different from the buffer used for
other spectroscopic experiments, as p300 is known to be stable in this
buffer. The anisotropy was then determined, followed by addition of
increasing amounts of unlabeled competing peptide. The excitation and
emission wavelengths were 480 and 520 nm, respectively. The excita-
tion and emission band passes were 10 and 5 nm, respectively. Anisot-
ropy (A) was calculated according to the following formula: A  (I 
I)/(I 
 2I), where I is the fluorescence intensity with parallel polar-
izers (0/0) and I is the fluorescence intensity with crossed polarizers
(0/90).
RESULTS AND DISCUSSION
Because we have attempted to work with the isolated p53-
(1–39) fragment, it is important to assess the structural and
functional integrity of this isolated domain. The functional
integrity of the 1–39 domain can be judged from its interaction
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with the natural receptors, e.g. TAF, Mdm2, or p300 (23).
Previous reports have suggested that this domain binds to TAF
and Mdm2 with high affinity (14, 24, 25). In addition, we have
measured the binding of the 1–39 domain of p53 and two of its
phosphorylated derivatives with p300. We have used fluores-
ceinated Ser15P peptide to measure binding by fluorescence
anisotropy. Fig. 1A shows the titration of fluoresceinated
Ser15P with increasing concentrations of p300. Anisotropy in-
creased and then quickly saturated. When the data were fitted
to a single-site binding equation, a dissociation constant of 81
nM was obtained. A qualitative estimate of binding constants of
Thr18P and p53-(1–39) was obtained using competition with
these unlabeled fragments. Fig. 1 (B and C) shows the decrease
in anisotropy when a complex of p300 and fluoresceinated
Ser15P, 360 nM each, was titrated with increasing concentra-
tions of either unlabeled Thr18P or p53-(1–39). In the case of
Thr18P, the anisotropy decreased very rapidly and returned to
the value of the free Ser15P peptide when the concentration
reached 1:1 stoichiometry with p300. This suggests total dis-
placement of the Ser15P peptide from the complex by an equal
concentration of Thr18P. This indicates a much higher binding
affinity of Thr18P as compared with Ser15P with p300. On the
other hand, p53-(1–39) only weakly displaced Ser15P from the
p300 complex. Even a 10-fold molar excess was not able to
displace it fully (displacement may be only 50%, as can be
estimated from anisotropy value), indicating at least several-
fold weaker affinity. Two papers have attempted to estimate
binding affinities of phosphorylated p53 protein (21, 23). It
appears that Ser-15 phosphorylated p53 binds much more
tightly than the unphosphorylated one and Thr18P also binds
very tightly compared with Ser15P. Thus, the isolated 1–39
domain faithfully reproduces the functional nature of the pro-
tein, indicating retention of functional integrity.
To find out if there were significant structural differences
between p53-(1–39) fragment and the 1–73 domain, chemical
shifts of both these fragments were compared (8). Almost com-
plete assignment of unmodified p53-(1–39) fragment was made
using standard two-dimensional homonuclear NOESY/TOCSY
strategy (26). The chemical shift differences of the amide pro-
tons are shown in Fig. 2A. The differences are largely confined
to the N- and C-terminal ends. The difference at the C-terminal
end is readily reconcilable, as the 1–39 fragment contains a free
-carboxyl group whereas the 1–73 fragment consists of con-
tinuing peptide chain. The difference in the N terminus is
likely to arise from the additional residues and N-terminal
modification of the recombinant protein (8). Only two residues,
16 and 28, in the middle showed greater than 0.1 ppm differ-
ence in chemical shifts. The implications of this observation are
not clear, although indirect effects of extra residues in the N
terminus cannot be completely ruled out. Thus, clearly the
1–39 fragment is similar to the 1–73 domain in structure and it
is unlikely that the 1–39 subdomain has any strong interaction
with the rest of the domain.
Chemical shifts can also be used to compare structural dif-
ferences between the phosphorylated and unphosphorylated
domains. We have compared the chemical shifts of amide res-
onances of the unphosphorylated and three phosphorylated
domains. Fig. 2 (B–D) shows the chemical shift differences for
amide protons between p53-(1–39) and Ser15P, Thr18P, and
Ser20P, respectively. In all three cases, the largest difference
was seen for the phosphorylated Ser/Thr residue, as expected.
In case of Thr18P, very significant shift was also observed for
the proximal residues, Phe19 and Ser-20. Interestingly, rela-
tively large shifts were seen for some residues, which are dis-
tant from the phosphorylation site. This distant effect was
found in all three phosphorylated domains, but appeared to be
more pronounced in Thr18P and Ser20P. Glu-28, Ser-37, Gln-
38, and Ala-39 showed changes of chemical shift greater than
0.1 ppm. In the case of Ser20P, modest chemical shift changes
were seen throughout residues 21–30. All the residues were
fairly distant from the modification site, suggesting long range
interactions present in the domain. In particular, the residues
at the C-terminal end, Ser-37, Gln-38, and Ala-39, are so dis-
tant from the phosphorylation site that secondary structure-
mediated change can be ruled out.
Another parameter that may reflect conformational change
is the coupling constant between NH and CH (JNH-H). This
coupling constant tends to have a low value (4–5 Hz) when
the Ramachandran angle () is in the helical range and a high
value (8–9 Hz) when the Ramachandran angle is in the
extended conformation range. Thus, for relatively mobile pep-
tide chains, perhaps lacking a unique conformation, a change
in the value of JNH-H may be a reflection of a change in the
distribution among different conformations. Fig. 3 shows the
difference of JNH-H values between p53-(1–39) and Ser15P and
Ser20P. It is clear that relatively large changes (2 Hz) in the
value of JNH-H occurred. The changes appear to be confined to
the central part of the molecule (between residues 16–28) and
FIG. 1. Binding of p300 with different phosphorylated deriva-
tives of p53-(1–39). A, titration of fluoresceinated Ser15P at a concen-
tration of 720 nM with increasing concentrations of p300. The line
shown is the best fit to a single-site binding equation. B, titration of 360
nM fluorescein-labeled Ser15P and 360 nM p300 complex with increas-
ing concentrations of Thr18P and p53-(1–39) (C). Lines in B and C are
merely polynomials and do not represent any binding equation. The
solution conditions were 20 mM Tris-HCl, pH 7.9, containing 100 mM
KCl. The temperature was 25  1 °C. Excitation and emission wave-
lengths were 480 and 520 nm, respectively. The error bars are derived
from three independent measurements. For clarity only every third
error bar is shown.
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the C-terminal residues. This pattern is very similar to the
changes in the chemical shift, supporting long distance struc-
tural changes upon phosphorylation.
From a number of studies, it is now well established that
tryptophan fluorescence in proteins is a sensitive probe of fold-
ing and tertiary structure (27). A number of fluorescence prop-
erties are sensitive to environment and solvent accessibility,
two of which are fluorescence emission maximum and Stern-
Volmer constant for collisional quenching. To assess the folded
nature of the domain, we have measured fluorescence proper-
ties of the only tryptophan present at position 23. This is in the
central part of the helix that spans the residues 17–26 (6) and
is close to many of the phosphorylation sites in this domain. It
is an important determinant for the Mdm2 interaction and
possibly the p300/CBP interaction (4, 28). Thus, environment of
this tryptophan residue may shed light on many important
aspects of structure and function of this domain. The emission
maxima of the unphosphorylated p53-(1–39) and Ser15P,
Thr18P, and Ser20P are 341, 343, 350, and 350 nm, respec-
tively (Table I). Fig. 4 shows the acrylamide quenching pattern
(Stern-Volmer plots) for all the above mentioned domains. It is
clear that the plots are linear in most cases and can be fitted
well to a Stern-Volmer equation with a single class of fluoro-
phore. Ksv (Stern-Volmer constant) of the domains are 3.9, 8.0,
11.0, and 11.2 M1 for unphosphorylated, Ser15P, Thr18P, and
Ser20P, respectively. As a control we have determined the Ksv
values of a peptide consisting of residues 17–28 (Pep53) and the
same peptide with five Aib substitutions (Bpep53). Aib substi-
tutions were made to predispose the peptide into a more helical
conformation. CD and NMR spectra indicate that Bpep53 is in
a helical conformation (data not shown). In both the above
mentioned peptides, the Stern-Volmer constants are high, 15.3
and 19.7 M1 for Pep53 and Bpep53, respectively. The emission
maxima are 350 nm in both cases. Clearly, the Ksv of the
tryptophan undergoes a dramatic reduction in going from
Pep53, a largely random coil, to p53-(1–39). Even induction of
helix by insertion of Aib does not reduce the Ksv or shift the
emission maximum. Thus, the blue-shifted emission maximum
in the p53-(1–39) fragment and lowering of Ksv may be the
result of long range interactions. The long range interactions
result in a folded conformation, which shields Trp-23 from
solvent. Change in the Ksv value upon phosphorylation sug-
gests a change in environment, and the corresponding red shift
of emission maximum suggests that this change leads to an
increased exposure of Trp-23. Properties of all the domains are
summarized in Table I. Interestingly, for p53-(1–39), the Stern-
Volmer plot is somewhat nonlinear, perhaps indicating the
presence of multiple conformations. The inset shows the emis-
sion maximum shift as a function of increasing acrylamide
concentrations for p53-(1–39). The shift of emission maximum
for a single tryptophan protein (without tyrosine as well)
FIG. 2. Comparison of chemical shifts of amide protons of different p53 N-terminal domains. A, chemical shift difference of p53-(1–39)
domain and recombinant p53-(1–73) domain at 5 °C. Chemical shifts of p53-(1–73) domain were taken directly from Lee et al. (6). p53-(1–39) chemical
shifts were obtained from TOCSY spectra using water as standard. Chemical shift differences between the unphosphorylated p53-(1–39) domain and
three phosphorylated derivatives: Ser15P (B), Thr18P (C), and Ser20P (D). The chemical shifts were obtained from standard NOESY/TOCSY
assignment procedure at 27 °C. All the spectra were taken in 10 mM phosphate buffer, pH 7.0, containing 100 mM NaCl. Seven prolines are not shown
for obvious reasons. Several resonances have zero chemical shift differences and hence do not appear as a bar in the figure.
FIG. 3. Difference of JNH-H between the p53-(1–39) domain and
Ser15P (A) and Ser20P (B). The coupling constants were obtained
from double quantum-filtered COSY using the algorithm of Kim and
Prestegard (21). The temperature was 27 °C. The spectra were taken in
10 mM phosphate buffer, pH 7.0, containing 100 mM NaCl. Prolines and
residues that cannot be assigned unambiguously have not been shown.
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strongly supports presence of multiple conformations for the
p53-(1–39). For the other phosphorylated fragments, no signif-
icant emission maximum shift could be detected (data not
shown).
Pulse field gradients NMR can be used to measure transla-
tional diffusion constants, which are directly related to the
hydrodynamic properties (29). Translational diffusion con-
stants thus can be used to measure hydrodynamic properties of
the transactivation domain and its phosphorylated derivatives,
which in turn may shed some light on the compactness of the
domains and states of aggregation. Fig. 5 shows the G2 versus
ln[intensity] plots for the unphosphorylated and the three
phosphorylated domains. All the diffusion constants are sum-
marized in Table II. The translational diffusion constant at
20 °C (D20,w) of the unphosphorylated p53-(1–39) is 1.31	 10
6
cm2 s1. This value is between that of sucrose and ribonuclease
A and consistent with a monomer of molecular mass of 4.35
kDa (30). The compactness of the domain can be gauged from
the fact that an unstructured 13-residue peptide has nearly the
same diffusion constant and hydrodynamic radius (31) (1.54 	
106 cm2 s1; see below for the axial ratios). Thus, the stabili-
zation of the tertiary structure in the 1–39 domain is likely to
be from intramolecular interactions rather than intermolecular
ones. The Ser-15 phosphorylated domain has a diffusion con-
stant of 1.21 	 106 cm2 s1, 8% lower than the unphospho-
rylated one. The Thr18P diffusion constant is also similar
(1.22–1.27 	 106 cm2 s1) as is the diffusion constant for
Ser20P (1.19–1.24 	 106 cm2 s1), all significantly different
from the unphosphorylated case. Determination of diffusion
constants at different concentrations does not show any signif-
icant change or trends, indicating that no significant aggrega-
tion occurs. This indicates that, upon phosphorylation, the
compactness of the 1–39 domain is partially lost. If one as-
sumes average hydration (0.34 g of water/g of protein) and
partial specific volume (0.73 cm3/g), one can qualitatively eval-
uate the shape of the protein through the Perrin factor, F (30).
Table I lists the Perrin factors and the axial ratios of the
corresponding ellipsoids. For the unphosphorylated 1–39 do-
main, the ratio is1:7.5 (for prolate as well as oblate ellipsoids)
indicating a nonspherical shape. In contrast, a completely un-
structured 13-residue peptide gave an axial ratio value of
1:20 by the same technique (31). A much longer peptide
chain, such as p53 transactivation domain, if completely disor-
dered, should give even higher axial ratios. Thus, we may
TABLE I
Properties of transactivation domain of p53 and its different
phosphorylated derivatives
Domain KSV
Emission
maximum
Perrin
factor
Axial
ratio
M
1 nm
p53-(1–39) 3.9 341 1.33 7.5
Ser15P 8.0 343 1.42 10.0
Thr18P 11.0 350 1.40 9.5
Ser20P 11.2 350 1.43 10.0
FIG. 4. Stern-Volmer plots of acrylamide quenching of the
tryptophan fluorescence of p53-(1–39) (), Ser15P (Œ), Thr18P
(), Ser20P (E), Pep53 (f), and Bpep53 (‚). The excitation wave-
length was 295 nm, and the emission was noted at 340 nm. The spectra
were recorded at ambient temperature, which was 25  1 °C. The
solution conditions were 10 mM phosphate buffer, pH 7.0, containing
100 mM NaCl. The inset shows the emission maximum shift upon
acrylamide quenching for p53-(1–39).
FIG. 5. G2 versus ln[intensity] plots for measurement of trans-
lational diffusion constant using pulse field gradient NMR for
p53-(1–39) domain, Ser15P, Thr18P, and Ser20P, as labeled. The
experiment was performed using a stimulated echo-based pulse se-
quence. The measurements were carried out at 27 °C in 10 mM phos-
phate buffer, pH 7.0, containing 100 mM NaCl. The unit for field
strength was gauss/cm. Based on three independent measurements, we
estimate that standard errors are 1%.
TABLE II
Diffusion constants of p53-(1–39) domain and its
phosphorylated derivatives
Domain Concentration Diffusion constant(	 106) D20,w
M cm2 s1
p53-(1–39) 280 1.31  0.02
p53-(1–39) 15P 109 1.21  0.01
p53-(1–39) 20P 854 1.19  0.02
p53-(1–39) 20P 427 1.21  0.01
p53-(1–39) 20Pa 214 1.24
p53-(39) 18P 990 1.27  0.02
p53-(39) 18P 495 1.22  0.00b
a Because of the extremely diluted nature, only two determinations
could be performed. In all other cases, three or four independent exper-
iments were done.
b The standard error calculates to 0.004, but was approximated to
zero in the second decimal place.
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conclude that p53-(1–39) has a folded conformation to some
degree. Phosphorylations increase the axial ratio. This indi-
cates a more open conformation of the phosphorylated domains.
To assess the secondary structural content of the domain in
the phosphorylated and unphosphorylated states, we have
measured the far-UV CD spectra. Small peptides display con-
siderable flexibility and predisposition only to certain confor-
mations. To accentuate the conformational preferences, pep-
tide CD spectra are often taken at lower temperatures. Hence,
we have measured CD spectra at 7.5 °C. Fig. 6 shows the CD
spectra of the unphosphorylated and Ser-15 phosphorylated
p53-(1–39). The CD spectrum of the unphosphorylated domain
exhibits small but significant mean residue ellipticity at 222
nm and a pronounced minimum around 200 nm. Considering
that the solution conformation of the domain to be an equilib-
rium mixture of -helix (characterized by a double minima at
208 and 222 nm) and an extended conformation (characterized
by a pronounced minimum at 190 nm), the CD spectrum of the
unphosphorylated domain suggests the presence of some frac-
tion of helical population. Upon phosphorylation, the absolute
CD intensity decreases slightly but with no change in spectral
shape, indicating very little change in secondary structure. The
other two phosphorylated domains show Ser15P like CD spec-
tra under similar conditions (data not shown). Interestingly,
the peptide Pep53 has no significant negative band at 222 nm
and its CD spectrum resembles that of an extended conforma-
tion. Previous NMR studies have suggested that the domain
1–73 contains a helix spanning residues 17–26 (6). This is
consistent with significant helical content of the fragment p53-
(1–39). The lack of any significant helical content of the peptide
Pep53 may therefore suggest the presence of long range inter-
actions in the 1–39 domain that stabilizes the helix.
Bis-ANS is widely used as a probe for hydrophobic regions of
proteins. The general experience with bis-ANS and ANS is that
they are incapable of binding to completely unfolded states.
This is evident from no detectable binding to proteins at con-
ditions that completely unfold the proteins (32). The hydropho-
bic patches in proteins that are thought to be important for
binding of this class of fluorescent probes require some orga-
nized structure to bring hydrophobic elements in a protein
chain in close proximity. We have thus probed organized struc-
ture using bis-ANS binding as a probe in p53-(1–39) and its
Ser-20 phosphorylated counterpart. Fig. 7 shows the binding
isotherms. It is clear that Ser20P is almost identical to the
buffer control suggesting no binding. On the other hand, there
is a significant additional fluorescence enhancement with p53-
(1–39). This provides additional support that the unphospho-
rylated domain has some elements of a folded structure, which
disappears or reduces upon phosphorylation.
The presence of long range interactions in the transactiva-
tion domain of p53 raises an interesting question about its
nature. The NMR study indicated that the central helix ex-
tends up to residue Leu-26 (6). The stretch of four contiguous
residues (PENN) that follow the helix has a high probability of
turn formation. A search for such a sequence (LPENNV)
through Protein Data Bank revealed five proteins that have
such a sequence with only one sequence mutation. In all such
cases, the residues adopt a turn conformation (Protein Data
Bank identification codes 1cpb, 1f4b, 1js4, 1sky, and 1ehi). If
the residues LPENNV adopt a turn in the p53 transactivation
domain, several C-terminal residues may interact with resi-
dues at the N-terminal side of the domain. This is consistent
with the observation that the last three residues show signifi-
cant chemical shift change upon phosphorylation that appears
to result in a more open structure. Why the phosphorylations
lead to more open states is not known at present. However, in
Thr18P, the hydroxyl group of Thr-18 may hydrogen-bond to
NH or to the -COOH group of Asp-21, contributing to the
stability of the helix. Phosphorylation would eliminate such
hydrogen bonds and in addition would cause charge repulsion,
destabilizing the helix.
One of the general mechanisms of transcription activation in
eukaryotes is by acetylation of histones and consequent in-
creased accessibility of the DNA toward proteins that includes
the transcription initiation machinery (33, 34). One of the
functions of the transcription activation factors such as p53 is
to localize itself in an appropriate region through sequence-
specific DNA binding activity and recruit a histone acetyltrans-
ferase such as p300/CBP in the locality (35). How this recruit-
FIG. 6. Circular dichroism spectra of unphosphorylated p53-
(1–39) domain (OO), Ser15P (– – –), and Pep53 (- - -). All spectra
were taken at 7.5 °C in 10 mM phosphate buffer, pH 7.0, containing 100
mM NaCl. The spectra were collected with a 2-mm path length cuvette,
around which chilled water was circulated. The temperature of the
sample was recorded by placing a thermocouple in the cuvette. Band-
width was 2 nm, and the scan speed was set at 20 nm/min. The spectra
shown here are smoothed.
FIG. 7. Bis-ANS titration of 10 M p53-(1–39) (), Ser20P (E),
and buffer (). The solution conditions were 10 mM phosphate buffer,
pH 7, containing 100 mM NaCl. The temperature was 25  1 °C.
Excitation wavelength was 387 nm, and the emission wavelength was
490 nm. The lines are fit with linear and hyperbolic equations and do
not signify any binding model. The error bars were derived from three
independent experiments. For clarity, only every third error bar is
shown.
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ment occurs is not well understood in terms of structural or
energetics principles. Activation of p53 in response to genotoxic
stress results in transcription activation from a number of
promoters. The N-terminal domain of p53 is the domain re-
sponsible for interaction with p300/CBP and its recruitment
(36). It has been suggested that the strength of interaction
between the transactivation domain and its partners correlates
with the degree of transcription activation (37). In case of
Ser15P, it has been shown that phosphorylation leads to en-
hanced interaction with CBP (28). The structural basis of this
enhanced interaction remains unclear.
Many transactivation domains are known to be acidic and
flexible (38). Flexibility implies a rapidly interconverting dis-
tribution of states. However, little is known about their struc-
tures. The p53 transactivation domain falls into this general
category. Recently, NMR studies have indicated that this do-
main has defined secondary structures. Based on lack of long
range nuclear Overhauser effects, it was suggested that the
domain lacks organized tertiary structure (8). Fluorescence
results and hydrodynamic properties reported here, however,
argue for presence of long range interactions and a folded
structure. Change of chemical shifts of residues distant from
the phosphorylation sites also argues in favor of long range
interactions. We believe that lack of long range nuclear Over-
hauser effects results from the flexible nature of the domain
and a consequent reduction of correlation time rather than an
unfolded conformation. Flexibility is also known in other do-
mains. It has been argued that such flexible structures allow
those domains to fit into “molds” of different receptor struc-
tures (39). This increase in ability to recognize different targets
comes at a cost of binding affinity as the entropic barrier for a
disorder-order transition has to be overcome. A similar argu-
ment can be advanced here. We propose that the flexible trans-
activation domain of p53 is composed of rapidly equilibrating
conformers, one quasi-globular and the others relatively open.
We have observed that fluorescence quenching of p53-(1–39)
leads to significant blue shift of the emission maximum, suggest-
ing multiple environments for the single tryptophan residue. It
has been proposed that transactivation domains interact with
multiple partners through semispecific hydrophobic regions (37).
In case of p53, the central helix appears to be the critical inter-
action point (40). In a folded structure, where the helix may be
partially shielded, the interaction energy with the partner pro-
teins may be reduced. Phosphorylations at different positions
shift the equilibrium toward the open forms to various degrees,
causing enhancement of protein-protein interaction.
CONCLUSION
By several techniques we have shown that the transactiva-
tion domain of p53 has a folded structure. It is likely that this
folded structure is mobile and lacks organized tertiary interac-
tions. Folded structures without organized tertiary interac-
tions are well known in proteins, of which molten globules are
the most ubiquitous. Such dynamic folded structures may be
important for proteins that interact with multiple receptors.
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